If the findings are verified in more patients, they might lead to a prognostic test that could help doctors estimate a woman's risk of cancer recurring near the surgical site.
Objective to investigate the expression of EMA and EGP-2 in breast carcinoma tissues, to analyze their relationship with clinical indexes and to observe the correlation with their expression.
3
结论:HER - 2可作为乳腺癌患者预后判断的指标。
Conclusion: HER-2 can serve as markers for prognosis judgment of breast cancer patients.